SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.53 Cr | ₹0.58 Cr | ₹0.28 Cr | ₹0.33 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.53 Cr |
| Mar2024 | ₹0.58 Cr |
| Mar2020 | ₹0.28 Cr |
| Mar2019 | ₹0.33 Cr |
How is Deferred Tax Assets / Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.53 Cr | -8.46 | |
| Mar2024 | ₹0.58 Cr | 110.55 | |
| Mar2020 | ₹0.28 Cr | -17.17 | |
| Mar2019 | ₹0.33 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹823.0 Cr | -0.2% | -8.5% | 9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -0.2% |
-8.5% |
9.9% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses